Based on these findings, our study aimed to investigate the expression profiles of the three lncRNAs (lnc-EGFR, SNHG1, and lincRNA-Cox2) in Egyptian patients with RRMS during active relapses and in remission in an attempt to assess their impact on MS activity and future progression. This evidence concerns the gene SNHG1 and myeloid sarcoma.